Illenberger J, Flores-Ramirez F, Pascasio G, Franco M, Mendonsa B, Martin-Fardon R
J Psychopharmacol. 2024; 38(7):647-660.
PMID: 38888086
PMC: 11407285.
DOI: 10.1177/02698811241260989.
Clare K, Park K, Pan Y, Lejuez C, Volkow N, Du C
Front Pharmacol. 2024; 15:1357422.
PMID: 38455961
PMC: 10917943.
DOI: 10.3389/fphar.2024.1357422.
Agarwal K, Joseph P, Zhang R, Schwandt M, Ramchandani V, Diazgranados N
Transl Psychiatry. 2024; 14(1):43.
PMID: 38245501
PMC: 10799859.
DOI: 10.1038/s41398-024-02756-8.
Iannucci J, ONeill K, Wang X, Mukherjee S, Wang J, Shapiro L
Int J Mol Sci. 2023; 24(22).
PMID: 38003274
PMC: 10671736.
DOI: 10.3390/ijms242216084.
Qiu X, Han X, Wang Y, Ding W, Sun Y, Lei H
Front Neurosci. 2023; 17:1270014.
PMID: 37965221
PMC: 10641398.
DOI: 10.3389/fnins.2023.1270014.
Updated Perspectives on the Neurobiology of Substance Use Disorders Using Neuroimaging.
Murnane K, Edinoff A, Cornett E, Kaye A
Subst Abuse Rehabil. 2023; 14:99-111.
PMID: 37583934
PMC: 10424678.
DOI: 10.2147/SAR.S362861.
Blunted Neurobehavioral Loss Anticipation Predicts Relapse to Stimulant Drug Use.
Mortazavi L, MacNiven K, Knutson B
Biol Psychiatry. 2023; 95(3):256-265.
PMID: 37567334
PMC: 10840879.
DOI: 10.1016/j.biopsych.2023.07.020.
ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seeking.
Illenberger J, Flores-Ramirez F, Matzeu A, Lutjens R, Martin-Fardon R
Neuropharmacology. 2023; 238:109666.
PMID: 37463637
PMC: 10529136.
DOI: 10.1016/j.neuropharm.2023.109666.
The Stage-Based Model of Addiction-Using to Investigate Alcohol and Psychostimulant Responses.
Cummins-Beebee P, Chvilicek M, Rothenfluh A
Int J Mol Sci. 2023; 24(13).
PMID: 37446084
PMC: 10341944.
DOI: 10.3390/ijms241310909.
Transcriptional and epigenetic regulation of microglia in substance use disorders.
Vilca S, Margetts A, Pollock T, Tuesta L
Mol Cell Neurosci. 2023; 125:103838.
PMID: 36893849
PMC: 10247513.
DOI: 10.1016/j.mcn.2023.103838.
Integrative Roles of Dopamine Pathway and Calcium Channels Reveal a Link between Schizophrenia and Opioid Use Disorder.
Thiagarajan S, Mok S, Ogawa S, Parhar I, Tang P
Int J Mol Sci. 2023; 24(4).
PMID: 36835497
PMC: 9966501.
DOI: 10.3390/ijms24044088.
Ventral tegmental area astrocytes modulate cocaine reward by tonically releasing GABA.
Yang J, Chen J, Liu Y, Chen K, Baraban J, Qiu Z
Neuron. 2023; 111(7):1104-1117.e6.
PMID: 36681074
PMC: 10079641.
DOI: 10.1016/j.neuron.2022.12.033.
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline....
Ceccanti M, Blum K, Bowirrat A, Dennen C, Braverman E, Baron D
J Pers Med. 2022; 12(12).
PMID: 36556236
PMC: 9782293.
DOI: 10.3390/jpm12122015.
Effects of dopamine D2/3 and opioid receptor antagonism on the trade-off between model-based and model-free behaviour in healthy volunteers.
Mikus N, Korb S, Massaccesi C, Gausterer C, Graf I, Willeit M
Elife. 2022; 11.
PMID: 36468832
PMC: 9721617.
DOI: 10.7554/eLife.79661.
Preclinical Characterization and Development on NAQ as a Mu Opioid Receptor Partial Agonist for Opioid Use Disorder Treatment.
Pagare P, Obeng S, Huang B, Marcus M, Nicholson K, Townsend A
ACS Pharmacol Transl Sci. 2022; 5(11):1197-1209.
PMID: 36407950
PMC: 9667545.
DOI: 10.1021/acsptsci.2c00178.
Early-life adversity increases anxiety-like behavior and modifies synaptic protein expression in a region-specific manner.
Hamdan J, Sierra-Fonseca J, Flores R, Saucedo Jr S, Miranda-Arango M, ODell L
Front Behav Neurosci. 2022; 16:1008556.
PMID: 36338879
PMC: 9626971.
DOI: 10.3389/fnbeh.2022.1008556.
Dose titration with the glucagon-like peptide-1 agonist, liraglutide, reduces cue- and drug-induced heroin seeking in high drug-taking rats.
Evans B, Stoltzfus B, Acharya N, Nyland J, Arnold A, Freet C
Brain Res Bull. 2022; 189:163-173.
PMID: 36038016
PMC: 10757750.
DOI: 10.1016/j.brainresbull.2022.08.022.
Epac2 in midbrain dopamine neurons contributes to cocaine reinforcement via enhancement of dopamine release.
Liu X, Vickstrom C, Yu H, Liu S, Snarrenberg S, Friedman V
Elife. 2022; 11.
PMID: 35993549
PMC: 9436413.
DOI: 10.7554/eLife.80747.
Influence of Selective Dopamine Agonist Ropinirole on Conditioned Place Preference and Somatic Signs of Morphine Withdrawal in Rats.
Shahzadi A, Yunusoglu O, Karabulut E, Sonmez H, Yazici Z
Front Behav Neurosci. 2022; 16:855241.
PMID: 35733518
PMC: 9207507.
DOI: 10.3389/fnbeh.2022.855241.
Clinical Observation of the Effects of Oral Opioid on Inflammatory Cytokines and Gut Microbiota in Patients with Moderate to Severe Cancer Pain: A Retrospective Cohort Study.
Wang H, Luo J, Chen X, Hu H, Li S, Zhang Y
Pain Ther. 2022; 11(2):667-681.
PMID: 35435623
PMC: 9098777.
DOI: 10.1007/s40122-022-00386-w.
